VIX Warned of SOX Fall. What’s Next?
The data and statistics say we should see more corrective action, but we also got one or two extremes from Friday’s action.
While Everyone Was Selling, I Initiated a New Position in This Mid-Cap Biotech
I made exactly one trade Friday — and I went to Denmark to do it.
Bearish Bets: Big-Cap Names to Short This Week
Some large-cap names are struggling to keep up with the rest of the market.
Planet Labs Breaks Its Trend, But I’m Buying the Weakness
Let’s review the quarterly results, what the chart looks like and why I’m adding.
Broadcom’s ‘Good’ Wasn’t Good Enough—Now the Setup Gets Interesting
In a market addicted to upside surprises, ‘priced to perfection’ gets sold. Is this now a buying opportunity?
What Really Broke Bitcoin?
A small sale by Strategy may have rattled investor confidence, but the technical damage was already underway.
While the Others Rally, This VIX Indicator Screams Caution
It’s an either/or market. The others made their move today, but the VIX may be ready to pop.
Buying CrowdStrike as Strong Quarter Indicates Acceleration
Sticking with this long-term price target for the cybersecurity giant.
I’m Eyeing 3 Names Amid Market Rotation
Here’s my strategy as the Dow rises as cash rotates out of overbought semiconductor stocks.
Rocket Lab Sees Insider Selling, But My Plan Is to Buy
Rocket Lab, a successful position for the portfolio, is getting knocked around by the space trade and insider sales.